comparemela.com

Latest Breaking News On - Test efficacy - Page 1 : comparemela.com

Orexin-2 Receptor Agonist for Narcolepsy Enters Phase 2 Trials

The phase 2 trial will evaluate the safety and efficacy of ALKS 2680, a novel orexin-2 receptor agonist, in patients with narcolepsy type 1.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.